26 February 2024

De Brauw advises underwriters on NewAmsterdam Pharma's USD 200 million public offering of shares and pre-funded warrants

Féline Goyarts+ 2 other team members

De Brauw advised the underwriters on the USD 200 million public offering of shares and pre-funded warrants by NASDAQ listed NewAmsterdam Pharma Company N.V.